AKT-Independent Signaling Downstream of Oncogenic PIK3CA Mutations in Human Cancer

Cancer Cell

Volumn 16, Issue 1, 2009, Pages 21-32

  Vasudevan, Krishna M ^a   Barbie, David A ^a,b,h   Davies, Michael A ^d   Rabinovsky, Rosalia ^a   McNear, Chontelle J ^a   Kim, Jessica J ^a   Hennessy, Bryan T ^d   Tseng, Hsiuyi ^a   Pochanard, Panisa ^a   Kim, So Young ^a,b   Dunn, Ian F ^a,b   Schinzel, Anna C ^a,b   Sandy, Peter ^b   Hoersch, Sebastian ^b   Sheng, Qing ^a   Gupta, Piyush B ^b   Boehm, Jesse S ^b   Reiling, Jan H ^e   Silver, Serena ^b   Lu, Yiling ^d   Stemke Hale, Katherine ^d   Dutta, Bhaskar ^d   Joy, Corwin ^d   Sahin, Aysegul A ^d   Gonzalez Angulo, Ana Maria ^d   Lluch, Ana ^f   Rameh, Lucia E ^g   Jacks, Tyler ^b   Root, David E ^b   Lander, Eric S ^b   Mills, Gordon B ^d   Hahn, William C ^a,b   Sellers, William R ^a,c   Garraway, Levi A ^a,b   more..

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^d UNIVERSITY OF TEXAS   (United States)

^e WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^f UNIVERSITY OF VALENCIA   (Spain)

^g BOSTON BIOMEDICAL RESEARCH INSTITUTE   (United States)

^h MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

CELLCYCLE

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOINOSITIDE 3 KINASE CATALYTIC ALPHA POLYPEPTIDE; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROTEIN KINASE B; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST TUMOR; CANCER CELL; CELL ANCHORAGE; CELL MEMBRANE; CELL MUTANT; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME SUBSTRATE; FEMALE; GENETIC ANALYSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TUMOR GROWTH;

EID: 67649382929     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2009.04.012     Document Type: Article

References (56)

1. Alessi D.R., James S.R., Downes C.P., Holmes A.B., Gaffney P.R., Reese C.B., and Cohen P. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr. Biol. 7 (1997) 261-269
2. Barbareschi M., Buttitta F., Felicioni L., Cotrupi S., Barassi F., Del Grammastro M., Ferro A., Dalla Palma P., Galligioni E., and Marchetti A. Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomas. Clin. Cancer Res. 13 (2007) 6064-6069
3. Bayascas J.R., Leslie N.R., Parsons R., Fleming S., and Alessi D.R. Hypomorphic mutation of PDK1 suppresses tumorigenesis in PTEN(+/-) mice. Curr. Biol. 15 (2005) 1839-1846
4. Blend M.J., Stastny J.J., Swanson S.M., and Brechbiel M.W. Labeling anti-HER2/neu monoclonal antibodies with 111In and 90Y using a bifunctional DTPA chelating agent. Cancer Biother. Radiopharm. 18 (2003) 355-363
5. Boehm J.S., Zhao J.J., Yao J., Kim S.Y., Firestein R., Dunn I.F., Sjostrom S.K., Garraway L.A., Weremowicz S., Richardson A.L., et al. Integrative genomic approaches identify IKBKE as a breast cancer oncogene. Cell 129 (2007) 1065-1079
6. Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., Hu L.S., Anderson M.J., Arden K.C., Blenis J., and Greenberg M.E. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96 (1999) 857-868
7. Carpten J.D., Faber A.L., Horn C., Donoho G.P., Briggs S.L., Robbins C.M., Hostetter G., Boguslawski S., Moses T.Y., Savage S., et al. A transforming mutation in the pleckstrin homology domain of AKT1 in cancer. Nature 448 (2007) 439-444
8. Casamayor A., Morrice N.A., and Alessi D.R. Phosphorylation of Ser-241 is essential for the activity of 3-phosphoinositide-dependent protein kinase-1: identification of five sites of phosphorylation in vivo. Biochem. J. 342 (1999) 287-292
9. Currie R.A., Walker K.S., Gray A., Deak M., Casamayor A., Downes C.P., Cohen P., Alessi D.R., and Lucocq J. Role of phosphatidylinositol 3,4,5-trisphosphate in regulating the activity and localization of 3-phosphoinositide-dependent protein kinase-1. Biochem. J. 337 (1999) 575-583
10. Depowski P.L., Rosenthal S.I., and Ross J.S. Loss of expression of the PTEN gene protein product is associated with poor outcome in breast cancer. Mod. Pathol. 14 (2001) 672-676
11. Dudek H., Datta S.R., Franke T.F., Birnbaum M.J., Yao R., Cooper G.M., Segal R.A., Kaplan D.R., and Greenberg M.E. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275 (1997) 661-665
12. Engelman J.A., Luo J., and Cantley L.C. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat. Rev. Genet. 7 (2006) 606-619
13. Flynn P., Wongdagger M., Zavar M., Dean N.M., and Stokoe D. Inhibition of PDK-1 activity causes a reduction in cell proliferation and survival. Curr. Biol. 10 (2000) 1439-1442
14. Frodin M., Antal T.L., Dummler B.A., Jensen C.J., Deak M., Gammeltoft S., and Biondi R.M. A phosphoserine/threonine-binding pocket in AGC kinases and PDK1 mediates activation by hydrophobic motif phosphorylation. EMBO J. 21 (2002) 5396-5407
15. Garcia-Martinez J.M., and Alessi D.R. mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1). Biochem. J. 416 (2008) 375-385
16. Gould J., Getz G., Monti S., Reich M., and Mesirov J.P. Comparative gene marker selection suite. Bioinformatics 22 (2006) 1924-1925
17. Gustin J.P., Karakas B., Weiss M.B., Abukhdeir A.M., Lauring J., Garay J.P., Cosgrove D., Tamaki A., Konishi H., Konishi Y., et al. Knockin of mutant PIK3CA activates multiple oncogenic pathways. Proc. Natl. Acad. Sci. USA 106 (2009) 2835-2840
18. Haruta T., Uno T., Kawahara J., Takano A., Egawa K., Sharma P.M., Olefsky J.M., and Kobayashi M. A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1. Mol. Endocrinol. 14 (2000) 783-794
19. Hooshmand-Rad R., Hajkova L., Klint P., Karlsson R., Vanhaesebroeck B., Claesson-Welsh L., and Heldin C.H. The PI 3-kinase isoforms p110(alpha) and p110(beta) have differential roles in PDGF- and insulin-mediated signaling. J. Cell Sci. 113 (2000) 207-214
20. Isakoff S.J., Engelman J.A., Irie H.Y., Luo J., Brachmann S.M., Pearline R.V., Cantley L.C., and Brugge J.S. Breast cancer-associated PIK3CA mutations are oncogenic in mammary epithelial cells. Cancer Res. 65 (2005) 10992-11000
21. Jia S., Liu Z., Zhang S., Liu P., Zhang L., Lee S.H., Zhang J., Signoretti S., Loda M., Roberts T.M., and Zhao J.J. Essential roles of PI(3)K-p110 beta in cell growth, metabolism and tumorigenesis. Nature 454 (2008) 776-779
22. Jones K.T., Greer E.R., Pearce D., and Ashrafi K. Rictor/TORC2 regulates Caenorhabditis elegans fat storage, body size, and development through sgk-1. PLoS Biol. 7 (2009) e60
23. Kang S., Bader A.G., and Vogt P.K. Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. Proc. Natl. Acad. Sci. USA 102 (2005) 802-807
24. King C.C., and Newton A.C. The adaptor protein Grb14 regulates the localization of 3-phosphoinositide-dependent kinase-1. J. Biol. Chem. 279 (2004) 37518-37527
25. Malo N., Hanley J.A., Cerquozzi S., Pelletier J., and Nadon R. Statistical practice in high-throughput screening data analysis. Nat. Biotechnol. 24 (2006) 167-175
26. Miller S.J., Xing X., Xi L., and Hung M.C. Identification of a specific DNA region required for enhanced transcription of HER2/neu in the MDA-MB453 breast cancer cell line. DNA Cell Biol. 15 (1996) 749-757
27. Moffat J., Grueneberg D.A., Yang X., Kim S.Y., Kloepfer A.M., Hinkle G., Piqani B., Eisenhaure T.M., Luo B., Grenier J.K., et al. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 124 (2006) 1283-1298
28. Nakamura N., Ramaswamy S., Vazquez F., Signoretti S., Loda M., and Sellers W.R. Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN. Mol. Cell. Biol. 20 (2000) 8969-8982
29. Neve R.M., Chin K., Fridlyand J., Yeh J., Baehner F.L., Fevr T., Clark L., Bayani N., Coppe J.P., Tong F., et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10 (2006) 515-527
30. O'Reilly K.E., Rojo F., She Q.B., Solit D., Mills G.B., Smith D., Lane H., Hofmann F., Hicklin D.J., Ludwig D.L., et al. mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt. Cancer Res. 66 (2006) 1500-1508
31. Oda K., Stokoe D., Taketani Y., and McCormick F. High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma. Cancer Res. 65 (2005) 10669-10673
32. Saal L.H., Johansson P., Holm K., Gruvberger-Saal S.K., She Q.B., Maurer M., Koujak S., Ferrando A.A., Malmstrom P., Memeo L., et al. Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity. Proc. Natl. Acad. Sci. USA 104 (2007) 7564-7569
33. Samuels Y., Wang Z., Bardelli A., Silliman N., Ptak J., Szabo S., Yan H., Gazdar A., Powell S.M., Riggins G.J., et al. High frequency of mutations of the PIK3CA gene in human cancers. Science 304 (2004) 554
34. Samuels Y., Diaz Jr. L.A., Schmidt-Kittler O., Cummins J.M., Delong L., Cheong I., Rago C., Huso D.L., Lengauer C., Kinzler K.W., et al. Mutant PIK3CA promotes cell growth and invasion of human cancer cells. Cancer Cell 7 (2005) 561-573
35. Sarbassov D.D., Guertin D.A., Ali S.M., and Sabatini D.M. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307 (2005) 1098-1101
36. Serunian L.A., Auger K.R., and Cantley L.C. Identification and quantification of polyphosphoinositides produced in response to platelet-derived growth factor stimulation. Methods Enzymol. 198 (1991) 78-87
37. She Q.B., Chandarlapaty S., Ye Q., Lobo J., Haskell K.M., Leander K.R., DeFeo-Jones D., Huber H.E., and Rosen N. Breast tumor cells with PI3K mutation or HER2 amplification are selectively addicted to Akt signaling. PLoS ONE 3 (2008) e3065
38. Slagsvold T., Marchese A., Brech A., and Stenmark H. CISK attenuates degradation of the chemokine receptor CXCR4 via the ubiquitin ligase AIP4. EMBO J. 25 (2006) 3738-3749
39. Solit D.B., Garraway L.A., Pratilas C.A., Sawai A., Getz G., Basso A., Ye Q., Lobo J.M., She Y., Osman I., et al. BRAF mutation predicts sensitivity to MEK inhibition. Nature 439 (2006) 358-362
40. Soukas A.A., Kane E.A., Carr C.E., Melo J.A., and Ruvkun G. Rictor/TORC2 regulates fat metabolism, feeding, growth, and life span in Caenorhabditis elegans. Genes Dev. 23 (2009) 496-511
41. Stemke-Hale K., Gonzalez-Angulo A., Lluch A., Neve R.M., Davies M.A., Carey M., Sahin A., Symmans W.F., Pusztai L., Nolden L.K., et al. An integrative genomic and proteomic analysis of PIK3CA, PTEN and AKT mutations in breast cancer. Cancer Res. 68 (2008) 6084-6091
42. Stephens L., Anderson K., Stokoe D., Erdjument-Bromage H., Painter G.F., Holmes A.B., Gaffney P.R., Reese C.B., McCormick F., Tempst P., et al. Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. Science 279 (1998) 710-714
43. Stinson S.F., Alley M.C., Kopp W.C., Fiebig H.H., Mullendore L.A., Pittman A.F., Kenney S., Keller J., and Boyd M.R. Morphological and immunocytochemical characteristics of human tumor cell lines for use in a disease-oriented anticancer drug screen. Anticancer Res. 12 (1992) 1035-1053
44. Tessier M., and Woodgett J.R. Role of the Phox homology domain and phosphorylation in activation of serum and glucocorticoid-regulated kinase-3. J. Biol. Chem. 281 (2006) 23978-23989
45. Tibes R., Qiu Y., Lu Y., Hennessy B., Andreeff M., Mills G.B., and Kornblau S.M. Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells. Mol. Cancer Ther. 5 (2006) 2512-2521
46. Torbett N.E., Luna A., Knight Z.A., Houk A., Moasser M., Weiss W., Shokat K.M., and Stokoe D. A chemical screen in diverse breast cancer cell lines reveals genetic enhancers and suppressors of sensitivity to PI3K isotype-selective inhibition. Biochem. J. 415 (2008) 97-110
47. Vanhaesebroeck B., and Alessi D.R. The PI3K-PDK1 connection: more than just a road to PKB. Biochem. J. 346 (2000) 561-576
48. Vanhaesebroeck B., Leevers S.J., Ahmadi K., Timms J., Katso R., Driscoll P.C., Woscholski R., Parker P.J., and Waterfield M.D. Synthesis and function of 3-phosphorylated inositol lipids. Annu. Rev. Biochem. 70 (2001) 535-602
49. Varnai P., and Balla T. Visualization of phosphoinositides that bind pleckstrin homology domains: calcium- and agonist-induced dynamic changes and relationship to myo-[3H]inositol-labeled phosphoinositide pools. J. Cell Biol. 143 (1998) 501-510
50. Virbasius J.V., Song X., Pomerleau D.P., Zhan Y., Zhou G.W., and Czech M.P. Activation of the Akt-related cytokine-independent survival kinase requires interaction of its phox domain with endosomal phosphatidylinositol 3-phosphate. Proc. Natl. Acad. Sci. USA 98 (2001) 12908-12913
51. Vivanco I., and Sawyers C.L. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat. Rev. Cancer 2 (2002) 489-501
52. Watton S.J., and Downward J. Akt/PKB localisation and 3′ phosphoinositide generation at sites of epithelial cell-matrix and cell-cell interaction. Curr. Biol. 9 (1999) 433-436
53. Xu J., Liao L., Qin J., Xu J., Liu D., and Songyang Z. Identification of flightless-I as a substrate of the cytokine-independent survival kinase CISK. J. Biol. Chem. 284 (2009) 14377-14385
54. Zeng X., Xu H., and Glazer R.I. Transformation of mammary epithelial cells by 3-phosphoinositide-dependent protein kinase-1 (PDK1) is associated with the induction of protein kinase Calpha. Cancer Res. 62 (2002) 3538-3543
55. Zhang L., Bewick M., and Lafrenie R.M. EGFR and ErbB2 differentially regulate Raf-1 translocation and activation. Lab. Invest. 82 (2002) 71-78
56. Zhao J.J., Liu Z., Wang L., Shin E., Loda M.F., and Roberts T.M. The oncogenic properties of mutant p110alpha and p110beta phosphatidylinositol 3-kinases in human mammary epithelial cells. Proc. Natl. Acad. Sci. USA 102 (2005) 18443-18448